How Magle Group focus their use of DSM
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Nyhet

How Magle Group focus their use of DSM

How Magle Group focus their use of DSM

The company aims to establish itself as a leader in life-changing healthcare innovations.

Watch Justin Pierce, CEO and Helena Ossmer Thedius, Chief Marketing and Innovation Officer, explain their technology platform of degradable starch microspheres (DSM), serving as the base for development of new products, in BioStock Studio.

Lorem ipsum dolor sit amet. Est omnis iusto eos velit nostrum et pariatur quod non. Consequuntur nemo id dolores tempora ut quis quis eum. Porro dolore rem voluptas iste. Consequuntur nemo id dolores tempora ut quis quis eum

Denna källa har få eller inga artiklar bakom betalvägg
Läs hela artikeln hos Biostock

Nyhetsbrev